Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel ...

Please provide your email address to receive an email when new articles are posted on . Researchers found reduced z scores for two lung function measures among children with gestational diabetes ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. When comparing median FEV 1 before vs. 3 years after ...

Being overweight or too skinny in childhood may adversely affect people's lung function as adults, new research shows. Previous studies have had mixed results when looking at a correlation between ...

A new method of scanning lungs is able to show the effects of treatment on lung function in real time and enable experts to see the functioning of transplanted lungs. This could enable medics to ...

Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel, discusses improvements in lung function observed in patients enrolled in the BOREAS trial. The results of the BOREAS ...

A clinical trial conducted in a neonatal intensive care unit has identified a new treatment protocol to improve lung growth and function among preterm infants. Adding two weeks of continuous positive ...

An expert explains how to protect your lungs from hay fever, dust and damp - The change in seasons can trigger a range of ...

Dupilumab reduced airway inflammation and mucus burden and enhanced airway volume and flow, which led to better lung function and improved asthma control in patients with moderate to severe type 2 ...

Here's another good reason to help your child reach and maintain a healthy weight: A new study warns that kids who are either too skinny or too fat are at risk for impaired lung function. However, if ...

An abnormal BMI in children -- be it high or low -- can now be associated with impaired lung function, but if their BMI is normalized before they reach adulthood, the impairment can be offset, ...

Tyr Pharma (NASDAQ:ATYR) said it plans to conduct a new Phase III trial of efzofitimod in pulmonary sarcoidosis after receiving feedback from the U.S. Food and Drug Administration at a recent Type C ...